Original news and analysis on international IP policy
A group of policymakers and other experts met this month in Geneva to discuss counterfeit and unsafe products and wrestled with possible balanced solutions to the problem. The event was hosted by the United States mission and supported by the US Chamber of Commerce. It included US Ambassador to the UN Betty E. King, among dozens of others.
As the jobless rate remain high and budgets tight, United States policymakers increasingly are looking for ways to boost domestic innovation in order to create new jobs and boost the economy. One such bill to be announced tomorrow, called the "Strategic Manufacturing & Job Repatriation Act" aims to develop a national manufacturing strategy to create American jobs, including by lowering access to early patent applications and prioritising university patents.
The global AIDS community meeting in Vienna last week ended with renewed determination to fight the epidemic but underlined an urgent need for increased funding to sustain scientific advances and universal access. Some warned against an intellectual property rights enforcement push threatening global access in particular through bilateral and regional trade agreements.
The World Health Organisation is following a complicated timeline for new mandates on combating fake medicines, creating alternative financing mechanisms for research and development on neglected diseases, and improving pandemic influenza preparedness.
MUNICH – Some experts in Europe are coming to agreement that a tipping point might have been reached with regard to biological patents. At a conference organised this week by the “no patents on seeds” initiative on the eve of a public hearing of the European Patent Office on cases involving the patenting of broccoli and tomatoes, non-governmental representatives and farmers associations from Europe and elsewhere said there were detectable changes in American jurisprudence and European governments seem to be rethinking the biopatent issue.
A last-chance negotiation of a draft protocol text on biodiversity access and benefit-sharing has been given yet another chance as delegates parted ways on Friday in Montreal without an agreement but with a tentative plan to reconvene to try to tie it up before a major UN Convention on Biological Diversity meeting in October.
Key international agencies for health, trade and intellectual property on Friday jointly organised a symposium on access to medicines in an effort to gather information and expertise as a basis of a collaborative response to the challenges of public health.
The 18th International AIDS conference opened its doors in Vienna on Sunday with a purpose of keeping the HIV issue high among international priorities in the context of a global economic crisis, and to promote universal access to treatment.
Innovation is a key factor in economic growth but is not only about research as it is a system with many different interacting parts including R&D as one of those elements, a senior developed nations group representative said this week. Governments need to promote policies that integrate the cross-cutting nature of innovation and favour evidence based decision making, he said.
Yesterday, the European Court of Justice ruled in a case pitching Monsanto against European importers of Argentinean soy meal, denying the US seed giant intellectual property rights over the exports of soy meal from Argentina to the European Union.
Filing of financial patents seems to be on a parallel upward trend with litigation in the United States, with large companies being prime targets, and individual or small entities owning the patents, according to a well-known US economist. This could be the consequence of low quality patents being granted, he said.
The plurilateral Anti-Counterfeiting Trade Agreement (ACTA) and other such regional negotiations are a “bad development” for multilateral agencies, the World Intellectual Property Organization director general has told Intellectual Property Watch.